These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 3552217)

  • 1. Plasma monitoring of tricyclic antidepressants: defining the therapeutic range for imipramine in depressed children.
    Preskorn SH; Weller E; Hughes C; Weller R
    Clin Neuropharmacol; 1986; 9 Suppl 4():265-7. PubMed ID: 3552217
    [No Abstract]   [Full Text] [Related]  

  • 2. Tricyclic antidepressants in prepubertal depressed children: review of the literature.
    Weller RA; Weller EB
    Hillside J Clin Psychiatry; 1986; 8(1):46-55. PubMed ID: 3527932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma concentrations of tricyclic antidepressants in clinical practice.
    Hollister LE
    J Clin Psychiatry; 1982 Feb; 43(2):66-9. PubMed ID: 7056706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tricyclic-resistant depression: treatment resistance or inadequate treatment?
    Lydiard RB
    J Clin Psychiatry; 1985 Oct; 46(10):412-7. PubMed ID: 3900051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of tricyclic antidepressants and clinical efficacy: review of the literature -- part II.
    Risch SC; Huey LY; Janowsky DS
    J Clin Psychiatry; 1979 Feb; 40(2):58-69. PubMed ID: 581671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research overview of drug therapy in recurrent and chronic depression.
    Prien RF
    Adv Biochem Psychopharmacol; 1985; 40():121-30. PubMed ID: 3895838
    [No Abstract]   [Full Text] [Related]  

  • 7. [Critical evaluation of the value and limitations of plasma assays of imipramine derivatives for therapeutic monitoring].
    Bonin B; Vandel B; Vandel S; Volmat R
    Therapie; 1986; 41(2):115-8. PubMed ID: 3726782
    [No Abstract]   [Full Text] [Related]  

  • 8. Lack of advantage for imipramine combined with lithium versus imipramine alone in the treatment of major depression--a double-blind controlled study.
    Shahal B; Piel E; Mecz L; Kremer I; Klein E
    Biol Psychiatry; 1996 Dec; 40(11):1181-3. PubMed ID: 8931923
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma level monitoring of antidepressants: theoretical basis and clinical application.
    Gram LF; Kragh-Sørensen P; Kristensen CB; Møller M; Pedersen OL; Thayssen P
    Adv Biochem Psychopharmacol; 1984; 39():399-411. PubMed ID: 6380231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular effects of tricyclic antidepressants in depressed patients with chronic heart disease.
    Veith RC; Raskind MA; Caldwell JH; Barnes RF; Gumbrecht G; Ritchie JL
    N Engl J Med; 1982 Apr; 306(16):954-9. PubMed ID: 7038497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma concentrations of imipramine and clinical response among depressed outpatients.
    Matuzas W; Javaid JI; Glass R; Davis JM; Ross JA; Uhlenhuth EH
    J Clin Psychopharmacol; 1982 Apr; 2(2):140-2. PubMed ID: 7042772
    [No Abstract]   [Full Text] [Related]  

  • 12. Tricyclic antidepressant concentrations in plasma: an estimate of their sensitivity and specificity as a predictor of response.
    Perry PJ; Zeilmann C; Arndt S
    J Clin Psychopharmacol; 1994 Aug; 14(4):230-40. PubMed ID: 7962678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of the effectiveness of two treatment strategies in inpatients with a depressive disorder. A double-blind study of imipramine followed by lithium addition versus fluvoxamine followed by lithium addition].
    Birkenhäger TK; van den Broek WW; Mulder PG; Bruijn JA; Moleman P
    Tijdschr Psychiatr; 2006; 48(4):271-81. PubMed ID: 16955991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tricyclic antidepressants--blood level measurements and clinical outcome: an APA Task Force report. Task Force on the Use of Laboratory Tests in Psychiatry.
    Am J Psychiatry; 1985 Feb; 142(2):155-62. PubMed ID: 3881999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imipramine treatment of depressed children: a double-blind pilot study.
    Petti TA; Law W
    J Clin Psychopharmacol; 1982 Apr; 2(2):107-10. PubMed ID: 7042769
    [No Abstract]   [Full Text] [Related]  

  • 16. Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo.
    Quitkin FM; Stewart JW; McGrath PJ; Tricamo E; Rabkin JG; Ocepek-Welikson K; Nunes E; Harrison W; Klein DF
    Br J Psychiatry Suppl; 1993 Sep; (21):30-4. PubMed ID: 8217065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial severity and diagnosis influence the relationship of tricyclic plasma levels to response: a statistical review.
    Boyer WF; Lake CR
    J Clin Psychopharmacol; 1987 Apr; 7(2):67-71. PubMed ID: 3584523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship of antiobsessional and antidepressant effects of tricyclic antidepressants.
    Mavissakalian M; Turner SM; Michelson L; Jacob R
    Psychopharmacol Bull; 1986; 22(1):161-6. PubMed ID: 3523574
    [No Abstract]   [Full Text] [Related]  

  • 19. Lithium in treatment and prevention of affective disorder. A VA-NIMH collaborative study.
    Pokorny AD; Prien RF
    Dis Nerv Syst; 1974 Jul; 35(7):327-33. PubMed ID: 17894091
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic drug monitoring for antidepressants: efficacy, safety, and cost effectiveness.
    Preskorn SH; Fast GA
    J Clin Psychiatry; 1991 Jun; 52 Suppl():23-33. PubMed ID: 1904862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.